의료진프로필

Graves' Disease and the Risk of Type 2 Diabetes: A Korean Population-Based Study

Cho, YY; Kim, B; Jin, SM; Jung, CH; Mok, JO; Kim, SW; Chung, JH; Han, KD; Kim, TH

The association between BMI and BRAFV600E mutation may differ by primary tumor size

Park, H; Heo, J; Ryu, HJ; Kim, MJ; Oh, YL; Kim, TH; Kim, SW; Chung, JH

Comparison of Patient-Reported Outcomes Between Active Surveillance and Immediate Lobectomy in Patients with Low-Risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS Cohort

Kim, MJ; Won, H; Kim, WB; Lee, EK; Lee, CY; Cho, SW; Baek, HS; Lee, YS; Kang, YE; Kim, SW; Kang, HC; Lee, JM; Kim, M; Jeon, MJ; Moon, JH

Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF V600E-Mutated Thyroid Cancer

Jeon, Y; Park, S; Lee, SH; Kim, TH; Kim, SW; Ahn, MJ; Jung, HA; Chung, JH

Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer

Kim, HI; Kim, WG; Kim, M; Ko, NG; Jin, M; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Choi, YL; Jeon, MJ; Kim, TY; Kim, WB; Kim, SW; Lee, DH; Jang, SJ; Kim, SW; Chung, JH; Kim, TH; Lee, SH

Adequate Dose of Levothyroxine for Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy in Patients with Differentiated Thyroid Cancer

Ryu, HJ; Choi, MS; Park, H; Kim, TH; Chung, JH; Park, SY; Kim, SW

The association between TSH and thyroid hormones in the normal or subclinical dysfunction range with left ventricular diastolic dysfunction

Jun, JE; Kim, TH; Kim, SW; Chung, JH; Kim, JH; Lee, YB; Kang, MR

Clinical Manifestations of Malignant Struma Ovarii: A Retrospective Case Series in a Tertiary Hospital in Korea

Ryu, HJ; Leem, D; Yoo, JH; Kim, TH; Kim, SW; Chung, JH

Malignancy Risk of Follicular Neoplasm (Bethesda IV) With Variable Cutoffs of Tumor Size: A Systemic Review and Meta-Analysis

Cho, YY; Ahn, SH; Lee, EK; Park, YJ; Choi, D; Kim, BY; Jung, CH; Mok, JO; Kim, CH; Kim, SW

Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma

Heo, J; Lee, S; Park, J; Yang, HR; Park, H; Ki, CS; Oh, YL; Kim, HI; Kim, SW; Chung, JH; Kim, K; Kim, TH

Mortality rate and causes of death in papillary thyroid microcarcinoma

Heo, J; Ryu, HJ; Park, H; Kim, TH; Kim, SW; Oh, YL; Chung, JH

Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy

Park, H; Ryu, HJ; Heo, J; Chung, MK; Son, YI; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Kim, SW; Chung, JH; Kim, JS; Kim, TH

Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case-control study

Hwang, Y; Oh, HK; Chung, JH; Kim, SW; Kim, JH; Kim, JS; Shin, MH

ASO Visual Abstract: Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status

Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH

Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status

Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH

Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea

Kim, HI; Kim, TH; Kim, H; Kim, SW; Hahm, JR; Chung, JH

Identification of Mutations in the Thyroxine-Binding Globulin (TBG) Gene in Patients with TBG Deficiency in Korea

Heo, J; Kim, SM; Ryu, HJ; Park, H; Kim, TH; Chung, JH; Park, HD; Kim, SW

Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study

Cho, YY; Kim, B; Choi, D; Kim, CH; Shin, DW; Kim, JS; Park, SJ; Kim, SW; Chung, JH; Han, K; Kim, TH

Ultrasonographic characteristics of H?rthle cell neoplasms: prediction of malignancy

Kim, MJ; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Lim, Y; Lee, SHY

The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy

Park, H; Heo, J; Kim, MJ; Lee, JH; Kim, MS; Jin, DK; Kim, TH; Chung, JH; Cho, SY; Kim, SW

Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients

Yang, HR; Park, H; Ryu, HJ; Heo, J; Kim, JS; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Jang, HW; Kim, TH; Kim, SW; Chung, JH

Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women

Park, H; Yang, H; Heo, J; Jang, HW; Chung, JH; Kim, TH; Min, YK; Kim, SW

Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study

Cho, YY; Kim, B; Shin, DW; Jang, HR; Kim, BY; Jung, CH; Kim, JH; Kim, SW; Chung, JH; Han, K; Kim, TH

Effect of TSH levels during active surveillance of PTMC according to age

Kim, HI; Jin, M; Ko, NG; Oh, YL; Shin, JH; Kim, JH; Kim, JS; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, WG; Kim, TH

Is Maintaining Thyroid-Stimulating Hormone Effective in Patients Undergoing Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer? A Systematic Review and Meta-Analysis

Won, HR; Jeon, E; Chang, JW; Kang, YE; Song, K; Kim, SW; Lim, DM; Ha, TK; Chung, KW; Kim, HJ; Park, YJ; Koo, BS

Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy

Park, H; Park, J; Yoo, H; Kim, S; Koh, JH; Jee, JH; Min, YK; Chung, JH; Kim, TH; Kang, M; Kim, SW

A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol

Lee¹, EK; Kang, YE; Park, YJ; Koo, BS; Chung, KW; Ku, EJ; Won, HR; Yoo, WS; Jeon, E; Paek, SH; Lee, YS; Lim, DM; Suh, YJ; Park, H; Kim, HJ; Kim, BH; Kim, M; Kim, SW; Yi, KH; Park, SK; Jung, EJ; Choi, JY; Bae, JS; Hong, JH; Nam, KH; Lee, YK; Yu, HW; Go, S; Kang, YM

Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations

Park¹, J; Lee, S; Park, J; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, K; Kim, TH

Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors

Park¹, J; Park, H; Kim, TH; Kim, SW; Jang, HW; Chung, JH

The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea

Park¹, SY; Kim, BH; Kim, M; Hong, AR; Park, J; Park, H; Choi, MS; Kim, TH; Kim, SW; Kang, HC; Chung, JH

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma

Park¹, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM

Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study

Lee¹, YB; Oh, YL; Shin, JH; Kim, SW; Chung, JH; Min, YK; Hahn, SY; Kim, TH

Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma

Jeon¹, MJ; Kang, YE; Moon, JH; Lim, DJ; Lee, CY; Lee, YS; Kim, SW; Kim, MH; Kim, BH; Kang, HC; Shong, M; Cho, SW; Kim, WB

TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients

Park¹, J; Lee, S; Kim, K; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH

Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels

Kim, H; Jung, J; Cho, YS; Choi, JY; Park, H; You-Bin Lee; Kim, SW; Chung, JH; Kim, TH

Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer

Kim, J; Park, J; Park, H; Choi, MS; Jang, HW; Kim, TH; Kim, SW; Chung, JH

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma

Park, H; Park, SY; Park, J; Choe, JH; Chung, MK; Woo, SY; Choi, JY; Kim, SW; Chung, JH; Kim, TH

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations

Park, H; Shin, HC; Yang, H; Heo, J; Ki, CS; Kim, HS; Kim, JH; Hahn, SY; Chung, YJ; Kim, SW; Chung, JH; Oh, YL; Kim, TH

Long-Term Outcomes and Causes of Death among Medullary Thyroid Carcinoma Patients with Distant Metastases

Park, H; Yang, H; Heo, J; Kim, TH; Kim, SW; Chung, JH

Surgeon Volume and Long-Term Oncologic Outcomes in Patients with Medullary Thyroid Carcinoma

Park, H; Kim, HI; Choe, JH; Chung, MK; Son, YI; Hahn, SY; Hwang, NY; Woo, SY; Kim, SW; Chung, JH; Kim, TH; Kim, JS

Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease

Kim, J; Choi, MS; Park, J; Park, H; Jang, HW; Choe, JH; Kim, JH; Kim, JS; Cho, YS; Choi, JY; Kim, TH; Chung, JH; Kim, SW

Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma

Park¹, H; Park, J; Choi, MS; Kim, J; Kim, H; Shin, JH; Kim, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH

Clinical Course from Diagnosis to Death in Patients with Well-Differentiated Thyroid Cancer

Park¹, H; Park, J; Park, SY; Kim, TH; Kim, SW; Chung, JH

Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules A Prospective Study ofBRAF-Prevalent Population

Cho¹, YY; Park, SY; Shin, JH; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Yim, HS; Kim, YL; Ki, CS; Kim, TH; Chung, JH; Kim, SW

The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study

Park¹, H; Kim, HI; Park, J; Park, SY; Kim, TH; Chung, JH; Choi, JY; Kim, SW

Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer

Kim¹, H; Park, SY; Choe, JH; Kim, JS; Hahn, SY; Kim, SW; Chung, JH; Jung, J; Kim, TH

Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma?

Park¹, KW; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Chung, JH

Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer

Kim¹, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH

Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study

Lee¹, EK; Kim, SM; Kim, BH; Kim, MJ; Lim, DJ; Kim, MH; Shin, DY; Kang, HC; Ahn, BC; Kim, SW; Ahn, HY; Park, YJ

Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis

Park¹, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH

Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma

Kim¹, BY; Choi, N; Kim, SW; Jeong, HS; Chung, MK; Son, YI

Non-immune-related hypothyroidism and its relationship with excess iodine

Kim¹, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH

Increased Morbidity of Major Depressive Disorder After Thyroidectomy: A Nationwide Population-Based Study in South Korea

Choi¹, KW; Kim, Y; Fava, M; Mischoulon, D; Na, EJ; Kim, SW; Shin, MH; Chung, MK; Jeon, HJ

Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model

Kim¹, H; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Park, KW; Lim, Y

Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma

Kim¹, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL

Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin

Cho¹, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW

Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015

Kim¹, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH

Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma

Kim¹, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH

Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study

Kim¹, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG

Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma

Park¹, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH

Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea

Oh¹, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH

Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study

Kim¹, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG

Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance

Lee¹, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL

Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles

Park¹, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH

Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma

Park¹, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH

Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea

Cho¹, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW

Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area

Kim¹, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY

Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma

Kim¹, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL

Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area

Kim¹, HJ; Park, HK; Byun, DW; Suh, K; Yoo, MH; Min, YK; Kim, SW; Chung, JH

Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis

Kim¹, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH

High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance

Kim¹, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW

Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)

Park¹, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW

Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis

Kim¹, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH

Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer

Kim¹, HI; Kim, M; Lee, SH; Park, SY; Kim, YN; Kim, H; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Kim, SW; Lee, DH; Park, K; Ahn, MJ; Chung, JH; Shong, YK; Kim, WG; Kim, TH

Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer

Jeon¹, MJ; Kim, YN; Sung, TY; Hong, SJ; Cho, YY; Kim, TY; Shong, YK; Kim, WB; Kim, SW; Chung, JH; Kim, TH; Kim, WG

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations

Hahn¹, SY; Kim, TH; Ki, CS; Kim, SW; Ahn, S; Shin, JH; Chung, JH

Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer

Kim¹, H; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW

Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size

Kim¹, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Jang, HW; Kim, YN; Kim, H; Ahn, HS; Kim, K; Kim, SW; Chung, JH

Validation of dynamic risk stratification in pediatric differentiated thyroid cancer

Sohn¹, SY; Kim, YN; Kim, HI; Kim, TH; Kim, SW; Chung, JH

Hormetic effect of triiodothyronine in metabolically healthy obese persons

Jun¹, JE; Kim, TH; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Kim, JH; Kim, SW; Chung, JH; Min, YK; Lee, MK

Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer

Kim¹, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Kim, JH; Hur, KY; Chung, JH; Kim, SW

Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma

Kim¹, TH; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Jeong, JG; Kim, SW; Chung, JH

Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer

Kim¹, TH; Ki, CS; Hahn, SY; Oh, YL; Jang, HW; Kim, SW; Chung, JH; Shin, JH

Subclinical thyroid dysfunction and risk of carotid atherosclerosis

Kim¹, H; Kim, TH; Kim, HI; Park, SY; Kim, YN; Kim, S; Kim, MJ; Jin, SM; Hur, KY; Kim, JH; Lee, MK; Min, YK; Chung, JH; Kang, M; Kim, SW

Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma

Kim¹, H; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Chi, SA; Jung, SH; Kim, YN; Kim, HI; Kim, SW; Chung, JH

Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study

Kim HJ1¹, Bae JC2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Jae Hwan J3, Kim JH4, Min YK4, Kim SW4, Chung JH5.

Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area

Kim HJ1¹, Kim NK2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Min YK2, Kim SW2, Chung JH3.

TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects

Jun JE1¹, Jin SM1, Jee JH2, Bae JC3, Hur KY1, Lee MK1, Kim SW1, Kim JH4,5.

Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?

Kim M1¹, Kim YN2, Kim WG1, Park S1, Kwon H1, Jeon MJ1, Ahn HS3, Jung SH4, Kim SW2, Kim WB1, Chung JH2, Shong YK1, Kim TH2, Kim TY1.

Comprehensive screening for PD-L1 expression in thyroid cancer

Ahn S1¹, Kim TH2, Kim SW2, Ki CS3, Jang HW4, Kim JS5, Kim JH5, Choe JH5, Shin JH6, Hahn SY6, Oh YL7, Chung JH8.

The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects

Lee DY1¹,2, Jee JH3, Jun JE1, Kim TH1, Jin SM1, Hur KY1, Kim SW1, Chung JH1, Lee MK1, Kim JH4,5.

Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area

Lee YB1¹, Cho YY2, Jang JY3, Kim TH1, Jang HW4, Chung JH1, Oh YL5, Kim SW1.

Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study

Hwangbo Y1¹,2, Kim JM3, Park YJ2, Lee EK1, Lee YJ1, Park DJ2, Choi YS4, Lee KD5, Sohn SY6, Kim SW6, Chung JH6, Lim DJ7, Kim MH7, Kim MJ3, Jo YS8, Shong MH8, Koong SS9, Hahm JR10, Jung JH10, Yi KH2,11.

First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant

Cho YY1¹,2, Song JS3, Park HD3, Kim YN1, Kim HI1, Kim TH1, Chung JH1, Ki CS4, Kim SW5.

Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication

Kim HI1¹, Kim TH1, Kim H1, Kim YN1, Jang HW2, Chung JH1, Moon SM3, Jhun BW3, Lee H3, Koh WJ3, Kim SW1.

Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study

Jun JE1¹, Jee JH2, Bae JC3, Jin SM1, Hur KY1, Lee MK1, Kim TH1, Kim SW1, Kim JH1.

A Prospective Study on Serum Methylmalonic Acid and Homocysteine in Pregnant Women

Choi R1¹, Choi S2, Lim Y3, Cho YY4, Kim HJ5, Kim SW6, Chung JH7, Oh SY8, Lee SY9.

A Prospective Study of Serum Trace Elements in Healthy Korean Pregnant Women

Choi R1¹, Sun J2, Yoo H3, Kim S4, Cho YY5, Kim HJ6, Kim SW7, Chung JH8, Oh SY9, Lee SY10,11.

TERT promoter mutations and long-term survival in patients with thyroid cancer

Kim TH1¹, Kim YE2, Ahn S3, Kim JY4, Ki CS5, Oh YL3, Kim K6, Yun JW7, Park WY7, Choe JH8, Kim JH8, Kim JS8, Kim SW1, Chung JH9.

Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence

Cho YY1¹, Jang HW2, Jang JY1, Kim TH1, Choe JH3, Kim JH3, Kim JS3, Kim SW1, Chung JH4.

Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer

Cho YY1¹, Chun S2, Lee SY2, Chung JH1, Park HD3, Kim SW4.

Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma The First Report in Nonwestern Countries

Joung JY1¹, Choi JH, Cho YY, Kim NK, Sohn SY, Kim SW, Chung JH.

Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications

Joung JY1¹, Kim TH1, Jeong DJ1, Park SM1, Cho YY1, Jang HW2, Jung YY3, Oh YL3, Yim HS4, Kim YL4, Chung JH1, Ki CS5, Kim SW1.

Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer

Sohn SY1¹, Park WY2,3, Shin HT2, Bae JS2, Ki CS4, Oh YL5, Kim SW6, Chung JH6.

Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques

Kim TH1¹, Jeong DJ1, Hahn SY2, Shin JH2, Oh YL3, Ki CS4, Kim JW4, Jang JY1, Cho YY1, Chung JH1, Kim SW1.

Iodine status in healthy pregnant women in Korea: a first report

Cho YY1¹, Kim HJ1,2, Oh SY3, Choi SJ3, Lee SY4, Joung JY1, Jeong DJ1, Sohn SY1, Chung JH1, Roh CR5, Kim SW6.

A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels

Kim TH1¹, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.

Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea

Seo GH1¹, Cho YY2, Chung JH2, Kim SW2.

Identification of p.Glu131Lys Mutation in the IHH Gene in a Korean Patient With Brachydactyly Type A1

Jang MA1¹, Kim OH2, Kim SW3, Ki CS1.

Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma

Kim HJ1¹, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH.

High Prevalence of Vitamin D Deficiency in Pregnant Korean Women: The First Trimester and the Winter Season as Risk Factors for Vitamin D Deficiency

Choi R1¹, Kim S2, Yoo H3, Cho YY4, Kim SW5, Chung JH6, Oh SY7, Lee SY8.

Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma

Kim HJ1¹, Lee JI, Cho YY, Lee SY, Kim JH, Jung BC, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim JH.

Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass

Park SM1¹, Joung JY1, Cho YY1, Sohn SY1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK1.

Elevated Risks of Subsequent Primary Malignancies in Patients With Thyroid Cancer: A Nationwide, Population-Based Study in Korea

Cho YY1¹, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.

Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma

Kim HJ1¹, Sung JY, Oh YL, Kim JH, Son YI, Min YK, Kim SW, Chung JH.

Effect of Iodine Restriction on Thyroid Function in Subclinical Hypothyroid Patients in an Iodine-Replete Area: A Long Period Observation in a Large-Scale Cohort

Joung JY1¹, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, Kim SW, Chung JH.

Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer

Woo HI¹, Kim SW, Ki CS, Shin JH, Oh YL, Kim JW, Chung JH.

Effectiveness of Ultrasonographic Screening for Thyroid Cancer: Round-table Conference in the National Evidence-based Healthcare Collaborating Agency (NECA) in conjunction with the Korean Thyroid Association

Shin S1¹, Park SE, Kim SY, Hyun MK, Kim SW, Kwon JW, Kim Y, Kim WB, Na DG, Park HA, Sheen SS, Yi KH, Chang HS, Cho JJ, Chung JH.

The Impact of Iodinated Contrast Agent Administered During Preoperative Computed Tomography Scan on Body Iodine Pool in Patients with Differentiated Thyroid Cancer Preparing for Radioactive Iodine Treatment

Sohn SY1¹, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, Kim TH, Jin SM, Bae JC, Lee SY, Chung JH, Kim SW.

Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells

Jin SM1¹, Jang HW, Sohn SY, Kim NK, Joung JY, Cho YY, Kim SW, Chung JH.

Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin

Chung HS1¹, Suh S2, Kim MY3, Kim SK3, Kim HK3, Lee JI3, Hur KY3, Kim JH3, Min YK3, Lee MS3, Kim KW3, Kim SW3, Chung JH3, Lee MK3.

Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas

Sohn SY1¹, Kim HJ, Jang HW, Kim SW, Chung JH.

Postinfectious Guillain-Barre syndrome in a patient with methimazole-induced agranulocytosis

Cho YY1¹, Joung JY, Jeong H, Je D, Hong YS, Suh S, Kim SW.

Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma

Kim HJ¹, Kim SW.

Association Between Excessive Urinary Iodine Excretion and Failure of Radioactive Iodine Thyroid Ablation in Patients with Papillary Thyroid Cancer

Sohn SY1¹, Choi JY, Jang HW, Kim HJ, Jin SM, Kim SW, Suh S, Hur KY, Kim JH, Chung JH, Kim SW.

Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma

Kim HJ1¹, Kim NK, Choi JH, Kim SW, Jin SM, Suh S, Bae JC, Min YK, Chung JH, Kim SW.

ERK Phosphorylation Is Not Increased in Papillary Thyroid Carcinomas with BRAF(V600E) Mutation Compared to That of Corresponding Normal Thyroid Tissues

Kim SW1¹, Kim HK, Lee JI, Jang HW, Choe JH, Kim JH, Kim JS, Hur KY, Kim JH, Chung JH.

Postoperative spindle cell nodule after thyroidectomy: A case mimicking recurrence with anaplastic transformation of thyroid cancer

Kim SW1¹, Oh YL, Choi JY, Lee JI, Chung JH, Kim JS.

Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer

Kim HJ1¹, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM, Jang HW, Suh S, Min YK, Chung JH, Kim SW.

Time trend in tumour size and characteristics of anaplastic thyroid carcinoma

Han JM1¹, Bae Kim W, Kim TY, Ryu JS, Gong G, Hong SJ, Kim JH, Oh YL, Jang HW, Kim SW, Chung JH, Shong YK.

Clinical Implication of Highly Sensitive Detection of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules: A Comparative Analysis of Three Molecular Assays in 4585 Consecutive Cases in a BRAF V600E Mutation-Prevalent Area

Lee ST1¹, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays

Chung KW1¹, Kim SW, Kim SW.

Identification of a cut-off for the macis score to predict the prognosis of differentiated thyroid carcinoma in children and young adults

Jang HW1¹, Lee JI, Kim HK, Oh YL, Choi YL, Jin DK, Kim JH, Chung JH, Kim SW.

Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma

Kim HK1¹, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, Jang HW, Hur KY, Kim JH, Min YK, Chung JH, Kim SW.

Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area

Kim HK1¹, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, Tan AH, Hur KY, Kim JH, Chung JH, Kim SW.

A Case of Resistance to Thyroid Hormone with Thyroid Cancer

Kim HK1¹, Kim D, Yoo EH, Lee JI, Jang HW, Tan AH, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.

DIFFERENCES IN SERUM THYROGLOBULIN MEASUREMENTS BY 3 COMMERCIAL IMMUNORADIOMETRIC ASSAY KITS AND LABORATORY STANDARDIZATION USING CERTIFIED REFERENCE MATERIAL 457 (CRM-457)

Lee JI1¹, Kim JY, Choi JY, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.

Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea

Lee JI1¹, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.

BRAF(V600E) Mutation Analysis in Fine-Needle Aspiration Cytology Specimens for Evaluation of Thyroid Nodule: A Large Series in a BRAF(V600E)-Prevalent Population

Kim SW1¹, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH.

Pathologic Changes and Glucose Homeostasis According to Expression of Human Islet Amyloid Polypeptide in Type 2 Diabetic Patients

Park JY1¹, No HS, Ahn YR, Oh SH, Kim YS, Kim SY, Jang KT, Kim SW, Chung JH, Min YK, Heo JS, Choi SH, Choi DW, Lee MS, Lee MK, Kim JH, Kim KW.

Usefulness of iodine/creatinine ratio from spot-urine samples to evaluate the effectiveness of low-iodine diet preparation for radioiodine therapy

Kim HK1¹, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, Tan AH, Hur KY, Kim JH, Chung JH, Kim SW.

SPURIOUS HYPERCALCITONINEMIA IN PATIENTS WITH NODULAR THYROID DISEASE INDUCED BY HETEROPHILIC ANTIBODIES

Kim JM1¹, Chung KW, Kim SW, Choi SH, Min HS, Kim JN, Won WJ, Kim SK, Lee JI, Chung JH, Kim SW.

Somatic Mutational Analysis of MEN1 and Phenotypic Correlation in Sporadic Parathyroid Tumors